Join the right offering for you:
Innovation Think Tank
Join the right offering for you:
Innovation Think Tank
Innovation Think Tank (ITT) is a part of the Chief Technology Office of Siemens Healthineers. Driven by the need of interdisciplinary and self-sustaining infrastructures which are accessible for the entire departments, ITT was established in 2005. The global ITT infrastructure includes multiple innovation labs and Innovation Think Tank programs across Germany, China, India, Turkey, the United States, United Arab Emirates, Canada, Jordan, Saudi Arabia, Egypt, Columbia, Brazil, Portugal, Australia, Switzerland, South Africa and United Kingdom, addressing projects from Siemens Healthineers locations and host institutions. The program success and recognition led to the establishment of ITT locations at prestigious healthcare institutions and universities.
ITT was founded and is headed globally by Prof. Sultan Haider, who is a Principal Key Expert at Siemens Healthineers (SHS), a title awarded to him by SHS Managing Board in the year 2008 for his outstanding innovation track record which includes the establishment of 89 ITT activity locations and over 500 inventions and patents filed. Furthermore, Prof. Haider has been awarded honorary directorships, professorships and has developed innovation infrastructures and implemented innovation management certification programs for top institutions.
Utilizing global self-sustaining innovation infrastructures to accelerate identifying and implementing new business opportunities
Facts & Figures
Learn more about ITT in our Publications
ITT Disease Pathways
The disease pathway framework is a novel ITT tool which describes the procedures involved in the healthcare provision throughout the development of various diseases. It is a holistic approach, which institutions can use to collect their own pain points for their relevant stakeholders and come up with their customized solutions. We identified important diseases worldwide based on the global burden of diseases (incidence, prevalence, mortality, DALYs, economic burden) and their social impact, and created the disease pathway frameworks. With a focus on open innovation in healthcare, the disease pathways, comprising pain points and possible solutions on emerging technologies to address the real-world challenges, have been curated and validated with clinical experts globally. Moreover, to highlight the effects of the pandemic on various diseases, the impact of COVID-19 has also been depicted in these pathway frameworks.
The facts and figures section provides a general and consolidated overview of common disease symptoms, risk factors and statistical figures on the global burden. The care plan section thoroughly analyzes the patient journey along the various stages of the disease life cycle. The provision of healthcare does not only involve diagnosis and treatment of diseases, but it also includes any healthcare procedure performed to maintain the state of wellbeing as well as management of disease to improve and restore health status. One of the unique features of the disease pathways is the inclusion of the stage before the onset of the subjected disease. Therefore, the disease pathways are demonstrated with eight stages: Prenatal, Prevention, Symptoms, Diagnosis, Treatment, Rehabilitation, Follow-up and Out-patient. The number of pathway stages to be used depends on the nature and need of the disease.
The disease pathways were analyzed from the perspective of more than 20 stakeholders for the different stages of the care plan. They can also be used for pain point and root cause identification, portfolio mapping and white spot analysis, product definition and decision proposition. A total of over 1,500 pain points were identified from multiple sources, including stakeholder interactions, clinical and disease workflow analyses, research, and requirements analyses of specific modalities. In addition, more than 1,900 ideas were proposed for the identified challenges. These solutions are influenced by technological advances, business models, process improvements and clinical aspects. Some of these ideas are already existing in healthcare, while the others are either in the research and development phase, or futuristic.
Learn more about the Disease Pathways by downloading the files here:
Learn more about and apply for our Certification Programs for Universities and Professionals and our Executive Leadership Program.
Dr. Charles Harr, Chief Medical Officer – Cardiovascular Thoracic Surgeon, WakeMed Health and Hospital
Prof. Michael Fisher, Director of Product Development, GCMI
Prof. Andrew Menard, Chief Administrative Officer, Radiology Johns Hopkins
Dr. Peter Schardt, Chief Technology Officer, Siemens Healthineers
Dr. Fatih Gül, Chief Operating Officer, Fakeeh University Hospital Dubai
Dr. Sonja Förster, Post Doctoral Researcher, ETH Zurich
Enis Sonemel, Managing Director of Turkey, Siemens Healthineers
Prof. Burak Acar, Professor of Electrical and Electronics Engineering & Prof. Suzan Uskudarli, Computer Engineering Department, Boğaziçi University Istanbul
Ufuk Eren, Chief Executive Officer, Volitan Global
News: Highlights of eITT 2022
The annual external Innovation Think Tank Exhibition (eITT 2021) showcased best practices and outcomes from ITT global locations of Siemens Healthineers and partner universities, hospitals, venture capitalists and start-ups.